BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 33707944)

  • 1. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
    Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
    Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy.
    Qu F; Wang P; Zhang K; Shi Y; Li Y; Li C; Lu J; Liu Q; Wang X
    Autophagy; 2020 Aug; 16(8):1413-1435. PubMed ID: 31674265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice.
    Yue W; Chen L; Yu L; Zhou B; Yin H; Ren W; Liu C; Guo L; Zhang Y; Sun L; Zhang K; Xu H; Chen Y
    Nat Commun; 2019 May; 10(1):2025. PubMed ID: 31048681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer.
    Xu P; Yao J; Li Z; Wang M; Zhou L; Zhong G; Zheng Y; Li N; Zhai Z; Yang S; Wu Y; Zhang D; Dai Z
    Int J Nanomedicine; 2020; 15():2659-2668. PubMed ID: 32368047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
    Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
    J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
    Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
    Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TiSe
    Chen L; Xue W; Cao J; Zhang S; Zeng Y; Ma L; Qian X; Wen Q; Hong Y; Shi Z; Xu Y
    J Nanobiotechnology; 2022 Oct; 20(1):453. PubMed ID: 36243711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focused ultrasound-augmented targeting delivery of nanosonosensitizers from homogenous exosomes for enhanced sonodynamic cancer therapy.
    Liu Y; Bai L; Guo K; Jia Y; Zhang K; Liu Q; Wang P; Wang X
    Theranostics; 2019; 9(18):5261-5281. PubMed ID: 31410214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy.
    Jiang Q; Qiao B; Lin X; Cao J; Zhang N; Guo H; Liu W; Zhu L; Xie X; Wan L; Tang R; Liang B; Wang D; Wang Z; Zhou Y; Ran H; Li P
    Theranostics; 2022; 12(1):59-75. PubMed ID: 34987634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradable Multifunctional Porphyrin-Based Porous Organic Polymer Nanosonosensitizer for Tumor-Specific Sonodynamic, Chemo- and Immunotherapy.
    Li M; Zhang Y; Zhang X; Liu Z; Tang J; Feng M; Chen B; Wu D; Liu J
    ACS Appl Mater Interfaces; 2022 Nov; 14(43):48489-48501. PubMed ID: 36281484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Ultrasound Nanobubbles Therapy for Prostate Cancer via Immuno-Sonodynamic Effect.
    Huang X; Chen Y; Zhong F; Gui B; Hu Y; Guo Y; Deng Q; Zhou Q
    Int J Nanomedicine; 2024; 19():2793-2806. PubMed ID: 38525011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.
    Zhu P; Chen Y; Shi J
    ACS Nano; 2018 Apr; 12(4):3780-3795. PubMed ID: 29613770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation.
    Huang T; Wu W; Wu J; Tan Y; Zhang M; Long H; Guo H; Zhang X; Zhou W; Zhang Q; Xie X; Xu M; Zhang C
    Front Immunol; 2023; 14():1124152. PubMed ID: 37051250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology and Immune Checkpoint Dual-Targeted Sonocatalytic Nanoagents for Enhancing Sonodynamic Tumor Therapy.
    Wei X; Feng Z; Huang J; Xiang X; Du F; He C; Zhou M; Ma L; Cheng C; Qiu L
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32810-32822. PubMed ID: 34232622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-assembled carrier-free nanosonosensitizer for photoacoustic imaging-guided synergistic chemo-sonodynamic cancer therapy.
    Dong C; Jiang Q; Qian X; Wu W; Wang W; Yu L; Chen Y
    Nanoscale; 2020 Mar; 12(9):5587-5600. PubMed ID: 32100776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.
    Huang J; Xiao Z; An Y; Han S; Wu W; Wang Y; Guo Y; Shuai X
    Biomaterials; 2021 Feb; 269():120636. PubMed ID: 33453632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-targeting sonosensitizer-loaded extracellular vesicles for chemo-sonodynamic therapy.
    Nguyen Cao TG; Truong Hoang Q; Hong EJ; Kang SJ; Kang JH; Ravichandran V; Kang HC; Ko YT; Rhee WJ; Shim MS
    J Control Release; 2023 Feb; 354():651-663. PubMed ID: 36682729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics.
    Zhou L; Huo M; Qian X; Ding L; Yu L; Feng W; Cui X; Chen Y
    J Nanobiotechnology; 2021 Apr; 19(1):112. PubMed ID: 33879173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma.
    Ma Y; Li J; Zhao Y; Hu B; Liu Y; Liu C
    Eur J Pharm Biopharm; 2022 Dec; 181():36-48. PubMed ID: 36307001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.